Among various adjuvants, flagellin is known as an adjuvant for immunotherapy that can induce increases of CD4 + and CD8 T + cells for various cancers including melanoma, colon, and breast cancers [19, 20, 27]. Here, CD4 is linked to breast carcinoma.